Dr. Bruno Wu Leads the Global Partnership Against Coronavirus Alliance (GPACA) to Procure Medical Supplies and Protective Medical Gear for U.S. Hospitals

NEW YORK, March 19, 2020 /PRNewswire/ -- Sun Seven Stars -- The Global Partnership Against Coronavirus  Alliance (GPACA), a newly formed humanitarian organization, announced today that through its Chairman Bruno Wu's Seven Stars Medical group it is able to accelerate procurement and delivery of over 30 different types of supplies and equipment including PPE (Personal Protective Equipment), and critical supplies of digital thermometers, N95 masks, gloves, facial protection, ventilators, testing kits and other critical medical supplies to assist U.S. hospitals in the battle to contain COVID-19.

Sourcing directly from China-based manufacturers, to streamline supply chain and procurement challenges currently experienced in the U.S., a portion of the medical supplies are already FDA approved and GPACA will seek speedy FDA approval for those which are not. Among the FDA approved supplies are Novel Corona Virus diagnostic testing kits, protective masks N95 and other protection supplies. In addition, GPACA can provide ventilators, digital thermometers, disposable gloves, personal protective equipment (PPE) kits, and ABI Real Time PCRs. The supplies, protective gear and other solutions were procured from China, Japan, South Korea, U.S. and Europe and will be provided as competitively as possible, on a cost-plus basis to cover modest shipping and administrative costs.

To ensure U.S. hospitals continue to receive necessary supplies related to COVID-19, GPACA has assembled an alliance of manufacturers. GPACA Chairman Dr. Bruno Wu appointed Richard Frankel, a former senior U.S. federal law enforcement official, as Chief Executive of the U.S. operations. GPACA will reach out to states and hospitals via governors, congressional representatives, and state senate leaders to discuss the best channels to provide their hospitals with medical supplies.

Separately, to help mitigate further infections, GPACA intends to introduce FDA-approved immune system boosting solutions in addition to Chinese traditional medicine based dietary supplemental solutions that have been proven effective in various cities in China.

"To defeat an enemy without borders, we must come together to ensure those in need receive the necessary life-saving resources and protect our medical heroes," said GPACA Chairman, Dr. Bruno Wu. "I'm very proud of our manufacturers and partners who have united under this humanitarian cause to quickly mobilize and make a positive impact."

GPACA's primary objective is to alleviate the worldwide suffering brought by the COVID-19 outbreak. GPACA's three key objectives are the following: (1) Find and study cures and solutions to protect against the further mutation and spreading of the virus; (2) Launch a global education campaign, utilizing both traditional and social media, to promote verified facts and information in order to reduce social panic and hysteria; and (3) Prevent the continued spread of outbreaks and assist in the coordination and establishment of public preventive policies for at-risk countries with an immediate focus on Africa, China, India, and South East Asia.

About GPACA
The Global Partnership Against Coronavirus Alliance (GPACA), a newly formed humanitarian organization, is working to bring rapid medical solutions, preventive care, policy proposals, and public awareness to counter the COVID-19 pandemic. GPACA's founding board members include Dr. Bruno Wu, Chairman of Sun Seven Stars Investment Group, Jay Park, President of Suponic Group, His Excellency Al Gurhair, Chairman of Essa Al Ghurair, and Dr. Vincenzo Costigliola, Founder and President of the European Medical Association.

Contact Information
GPACA
c/o 55 Broadway, 19th Floor
New York, NY 10006
Media Contact: Tony Sklar
Tel: +1 (917) 664-6307
[email protected]

SOURCE Sun Seven Stars